Verrica PharmaceuticalsVRCA
13F holders, Q2 2025 (June 30)5holders
$0.53avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Verrica Pharmaceuticals Inc. (VRCA) in their 13F filings. The largest holders were Marshall Wace, LLP ($66K), Beck Mack & Oliver LLC ($37K) and EverSource Wealth Advisors, LLC ($26).
- Company
- Verrica Pharmaceuticals Inc.
- CUSIP
- 92511W207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $103K |
| Exits | 0 | $0 |
Ownership 5 holders
| Marshall Wace, LLP | 0.00% | New | 123,953 | $66K |
| Beck Mack & Oliver LLC | 0.00% | New | 70,000 | $37K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 49 | $26 |
| Essential Partners LLC | 0.00% | — | 15 | $8 |
| SBI Securities Co., Ltd. | 0.00% | New | 2 | $1 |
"% of holder's portfolio" is VRCA's weight in each manager's 13F, not the share of Verrica Pharmaceuticals Inc. the manager owns.